Comment the results of Figure 3 Figure 3 presents the results of the MTS assay and expresses the results of the cell survival as afunction of the DSG concentration.HUCCT1QBC939SK-ChA-1100100-24 h10024 h24 h48 h80-48 h80-80-48 h72 h72 h72 h60-60-60-40-40-40-20-20-20-0-102040102040801020408080Concentration of DSG (uM)Concentration of DSG (uM)Concentration of DSG (uM)HUH28RBEMz-ChA-1100,100-24 h100O 24 hO 24 h48 h80-O 48 h80-80-48 h72 h72 h72 h60-60-40-40-40-2020-20-1020408010204010204080Concentration of DSG (uM)Concentration of DSG (uM)Concentration of DSG (uM)Cell survival (%)Cel survival (%)001Cel survival (9%)Cell survival (%)0 010 01Cell survival (%)Cel survival (%)0 01O 01

The MTS assay is a type of assay that is used to measure cell proliferation, cell viability and…

Figure 3 presents the results of the MTS assay and expresses the results of the cell survival as a function of the DSG concentration. HUCCT1 QBC939 SK-ChA-1 100 100, 24 h 100 O 24 h O 24 h 48 h 80- 48 h 80어 80어 O 48 h 72 h 72 h 72 h 60- 60- 60어 40- 40- 40- 20- 20- 20- 10 20 40 80 10 20 40 80 10 20 40 80 Concentration of DSG (uM) Concentration of DSG (µM) Concentration of DSG (uM) HUH28 RBE Mz-ChA-1 1007 100, 100 O 24 h O 24 h O 24 h 48 h 80- 48 h 80- 80- 48 h 72 h 72 h 72h 60어 60- 60- 40- 40어 40- 20- 20- 20- 20 Concentration of DSG (uM) 10 40 80 10 20 40 10 20 40 80 Concentration of DSG (uM) Concentration of DSG (uM) Cell survival (%) Cell survival (%) Cell survival (%) 0 01 (%) JeAAuns 1an 0 01 0 01

Figure 3 presents the results of the MTS assay and expresses the results of the cell survival as a function of the DSG concentration. HUCCT1 QBC939 SK-ChA-1 100 100, 24 h 100 O 24 h O 24 h 48 h 80- 48 h 80어 80어 O 48 h 72 h 72 h 72 h 60- 60- 60어 40- 40- 40- 20- 20- 20- 10 20 40 80 10 20 40 80 10 20 40 80 Concentration of DSG (uM) Concentration of DSG (µM) Concentration of DSG (uM) HUH28 RBE Mz-ChA-1 1007 100, 100 O 24 h O 24 h O 24 h 48 h 80- 48 h 80- 80- 48 h 72 h 72 h 72h 60어 60- 60- 40- 40어 40- 20- 20- 20- 20 Concentration of DSG (uM) 10 40 80 10 20 40 10 20 40 80 Concentration of DSG (uM) Concentration of DSG (uM) Cell survival (%) Cell survival (%) Cell survival (%) 0 01 (%) JeAAuns 1an 0 01 0 01

Essentials of Pharmacology for Health Professions

7th Edition

ISBN:9781305441620

Author:WOODROW

Publisher:WOODROW

Chapter14: Antineoplastic Drugs

Section: Chapter Questions

Problem 4CRQ

See similar textbooks

Similar questions

Monoclonal antibodies are produced by immunizing a mouse with a particular antigen, then removing its spleen. Individual B cells producing mouse antibodies specific for the antigen are isolated from the spleen, then fused with cancer cells. Each of the resulting hybrid cells can be cloned, which means it can be cultured indefinitely in the laboratory. The resulting cell lines produce and secrete antibodies that recognize the antigen to which the mouse was immunized. These antibodies are called monoclonal antibodies. Some monoclonal antibodies are used for passive immunization. They are effective, but only in the immediate term. Antibodies that are produced by one’s own immune system can last up to about six months in the bloodstream, but those delivered in passive immunization often last for less than a week. Why the difference?
How can we easily determine VEGF expression in a western blot experiment? By using fluorescent microscopy to view its transport into the cell By using a primary antibody targeting VEGF By adding purified VEGFR to an SDS polyacrylamide gel By doing a mass spectrometry analysis
Which of the following is not correct for the cytogenetic techniques? Samples can be taken in non-sterile conditions Culture time varies according to the type of tissue In GTG banding technique, chromosomes are treated with trypsin to denature proteins G-Banding is the most used banding type PLEASE ASAP I WILL RATE
what is the frequency of the rarest variant you can detect during deep sequencing of a tumor cell if you coverage is 250X? - 0.5% - 0.4% - 25% - 4%
One of the ways that we know what the RB protein does in cells is that its inactivation is a common priority of tumor-initiating viruses. What advantage would a virus gain by inactivating RB function in its host cell?
With respect to recombinant vaccines, it is CORRECT to state that: * (Only one statement is correct) (a) Protein subunit vaccines are formulated with the expression vector encoding the immunogenic protein or protein fragment (b) Recombinant carrier organisms are genetically modified to contain the pathogenic protein of the organism that will be the target of the vaccine (c) Nucleic acid vaccines are formulated with DNA or RNA molecules that, once internalized by cells, will generate recombinant proteins that will trigger the immune response against the desired pathogen (d) Unlike DNA vaccines, mRNA vaccines do not need to be internalized by cells, being recognized as foreign molecules to the organism that received them. (e) Laboratory-produced phages can be used as delivery tools in DNA vaccines, which will allow the expression of immunogenic proteins to the organism that received them (f) Pseudoviral particles (VLPs) are produced in cells that receive expression vectors…
A graduate student who has not taken BIOL 519 thinks they have discovered a new oncogene that could cause breast cancer. The student transfects cells with this oncogene and finds that the cells proliferate uncontrollably. The student next designs a PCR assay that will detect the presence of the oncogene in cancerous breast tissue. The student sets up the assay and analyzes the presence of the oncogene in normal and tumor issue samples (See data below). The student is disappointed to see that the potential oncogene is present at similar levels in both the normal and tumor tissue. Therefore, the student concludes that this gene is not an oncogene. Do you agree with this conclusion? Justify your answer (5-6 senetences max).
Which of the following most closely depicts the order of the RAS-RAF pathway in mutated cells? -ERK-MEK-BRAF-RAS -RAS-BRAF-MEK-ERK -MEK-RAS-BRAF-ERK -BRAF-MEK-ERK-RAS
Which of the following best describes the approach that wasused in the first gene therapy trial for treating SCID?a. The normal ADA gene was introduced by injecting liposomesdirectly into the patients’ bodies. b. Lymphocytes were removed from a SCID patient, the normalADA gene was transferred into the lymphocytes vialiposomes,and then the lymphocytes were returned to thepatient’s body.c. Lymphocytes were removed from a SCID patient, the normalADA gene was transferred into the lymphocytes via a retrovirus,and then the lymphocytes were returned to thepatient’s body.d. None of the above describe the approach used in the trial.
You are counting plaques on your plaque assay plates made from serial dilutions of your high titer lysate. Your 10-5 plate has 615 plaques although some are butting up against each other so it is difficult to get an accurate count. Your 10-6 plate has 42 plaques, and your 10-7 plate has only 1 plaque. Which plate would probably yield the most accurate titer calculation of your phage and why is it more trustworthy than the others?
I need to make an antibody for the extracellular portion of the Notch receptor. I have made S35 labelled Delta and my boss has given me an antibody that recognizes Delta and is conjugated to a chromophore that gives off light. Place the following statements in order beginning with labeling. HINT: Labeling, protein enrichment, immune response, making monoclonal cell lines, antigen screening of monoclonal cell lines. A) Hybridoma cells are selected by plating them in HAT buffer. B) Using direct ELISA you coat individual tissue culture wells/dishes with a single monoclonal antibody. C) I detect my protein fraction using a geiger counter. D) You add a solution containing radiolabeled Notch extracellular domain to the wells. E) You only keep monoclonal hybridoma cell lines that give light. The other cell lines you throw away. You have your antibody! F) I centrifuge my homogenate in a sugar or salt gradient. G) I inject a mouse with my protein, giving booster shoots every week. H)…
Humanized monoclonal antibodies are best described as a. antibodies made in mice in which the mouse antibody genes have been replaced with human equivalents b. human antibodies in which the CDR loops have been replaced by mouse-derived CDRs of the desired specificity c. antibodies made in culture by human hybridomas d. antibodies containing mouse Fab regions of both the heavy and light chain and human Fc regions e. antibodies containing human Fab regions of both the heavy and light chain and mouse Fc regions.